ClinicalTrials.gov
ClinicalTrials.gov Menu

Procalcitonin Level and Kinetics in Children With Bacterial Infections

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00714402
Recruitment Status : Completed
First Posted : July 14, 2008
Last Update Posted : May 18, 2011
Sponsor:
Information provided by:
Shaare Zedek Medical Center

July 9, 2008
July 14, 2008
May 18, 2011
August 2008
Not Provided
time to defervescence [ Time Frame: discharge ]
Same as current
Complete list of historical versions of study NCT00714402 on ClinicalTrials.gov Archive Site
length of hospitalization [ Time Frame: discharge ]
Same as current
Not Provided
Not Provided
 
Procalcitonin Level and Kinetics in Children With Bacterial Infections
Procalcitonin Level as a Prognostic Marker and Its' Kinetics in Children With Bacterial Infections

The purposes of this study are:

  1. To determine whether procalcitonin level at admission of pediatric patients with bacterial infections can be used as a marker for prediction of defervescence and hospitalization length
  2. To examine the kinetics of procalcitonin in pediatric patients with bacterial infections and persistent fever
Not Provided
Observational
Observational Model: Case-Only
Time Perspective: Prospective
Not Provided
Retention:   None Retained
Description:
whole blood
Non-Probability Sample
hospitalized patients at date of admission
  • Bacterial Infections
  • Bacteremia
  • Meningitis
  • Urinary Tract Infection
  • Mastoiditis
  • Lobar Pneumonia
  • Septic Arthritis
  • Cellulitis
  • Osteomyelitis
Not Provided
a
children with proven of probable invasive bacterial infections

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
50
Same as current
Not Provided
Not Provided

Inclusion Criteria:

  • Positive blood, urine, synovial, bone, pleural effusion, abscess or CSF culture
  • Cellulitis, lobar pneumonia, osteomyelitis,
Sexes Eligible for Study: All
up to 16 Years   (Child)
No
Contact information is only displayed when the study is recruiting subjects
Israel
 
 
NCT00714402
pct.ctil
Not Provided
Not Provided
Not Provided
Yechiel Schlesinger, Shaare Zedek Medical Center
Shaare Zedek Medical Center
Not Provided
Principal Investigator: Yechiel Schlesinger, MD Shaare Zedek Medical Center
Shaare Zedek Medical Center
January 2009